BEAM THERAPEUTICS INC shareholders Q2 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Reynders McVeigh Capital Management, LLC 67,875$2,627,0000.20%
K.J. Harrison & Partners Inc 16,497$639,0000.17%
Pearl River Capital, LLC 17,976$696,0000.16%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 3,804$147,0000.15%
Nikko Asset Management Americas, Inc. 291,962$10,762,0000.13%
Rock Springs Capital Management LP 111,430$4,313,0000.13%
CAPITAL ADVISORS INC/OK 108,746$4,210,0000.13%
Clarius Group, LLC 28,111$1,088,0000.11%
Granahan Investment Management 80,928$3,133,0000.11%
Jump Financial, LLC 61,614$2,386,0000.10%
Trexquant Investment LP 57,677$2,233,0000.10%
SEVEN EIGHT CAPITAL, LP 5,908$229,0000.09%
GILDER GAGNON HOWE & CO LLC 131,777$5,101,0000.09%
OCCUDO QUANTITATIVE STRATEGIES LP 27,309$1,057,0000.09%
Green Alpha Advisors, LLC 9,769$378,0000.09%
ClariVest Asset Management LLC 46,249$1,790,0000.08%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 326,494$12,639,0000.06%
Family Management Corp 5,715$221,0000.06%
Cubist Systematic Strategies, LLC 204,455$7,914,0000.05%
E Fund Management Co., Ltd. 13,237$512,0000.05%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q2 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.